Alexa

J&J 4Q profit jumps on higher sales, lower charges

J&J 4Q profit jumps on higher sales, lower charges

Higher sales helped Johnson & Johnson post a much bigger fourth-quarter profit than a year ago, when a slew of charges depressed results.
The U.S.-based maker of prescription drugs, consumer health products and medical devices says net income was $2.57 billion, or 91 cents per share, up from $218 million, or 8 cents per share, in 2011's fourth quarter.
Excluding about $800 million in one-time acquisition and litigation charges, earnings in the latest quarter would have been $3.38 billion, or $1.19 per share. That beat the expectation of analysts by 2 cents per share.
The company says revenue totaled $17.56 billion, just shy of analysts' average estimate of $17.69 billion.
J&J said it expects full-year profit of $5.35 to $5.45 per share. Analysts had expected $5.49.


Updated : 2021-01-19 16:56 GMT+08:00